Warning letter
Our Lady of Bellefonte Hospital: warning letter of Jun 1, 2012
FDA warning letter 302681 · Center for Drug Evaluation and Research
Key facts
| Reference number | 302681 |
|---|---|
| Company | Our Lady of Bellefonte Hospital |
| Subject | Institutional Review Board (IRB) |
| Issue date | Jun 1, 2012 |
| Posted date | Jun 1, 2012 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 56.107, 56.108, 56.108(a), 56.115(a)(1), 56.115(a)(5), 56.108(c), 56.109(e), 56.110(b), 56.115(a)(6) |
| Inspection city | Ashland |
| Inspection ZIP | 41101 |
| Inspection start date | Jan 3, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: